Jimi Olaghere/LinkedIn
Jun 24, 2026, 16:09
Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
Jimi Olaghere, Co-Founder at Sugarloaf Capital, shared a post on LinkedIn:
“It’s not too late to register for this free hybrid event hosted by NHLBI – Blood Research and Education and Sickle Cell Disease Association of America, Inc. — National.
I’ve seen firsthand what happens when researchers, clinicians, patients, and families work together – It needs to be the standard.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation